GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
34.98
+0.67 (1.95%)
Dec 3, 2024, 1:49 PM EST - Market open

GSK Revenue

GSK had revenue of 8.01B GBP in the quarter ending September 30, 2024, a decrease of -1.66%. This brings the company's revenue in the last twelve months to 31.31B, up 5.59% year-over-year. In the year 2023, GSK had annual revenue of 30.33B with 3.42% growth.

Revenue (ttm)
31.31B GBP
Revenue Growth
+5.59%
P/S Ratio
n/a
Revenue / Employee
445,949 GBP
Employees
70,212
Market Cap
69.22B USD

Revenue Chart

* This company reports financials in GBP.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202330.33B1.00B3.42%
Dec 31, 202229.32B4.63B18.74%
Dec 31, 202124.70B342.00M1.40%
Dec 31, 202024.35B-9.40B-27.85%
Dec 31, 201933.75B2.93B9.52%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CVS Health 367.25B
McKesson 330.19B
Cencora 293.96B
HCA Healthcare 69.62B
Takeda Pharmaceutical 31.73B
Becton, Dickinson and Company 20.18B
Haleon 15.07B
Regeneron Pharmaceuticals 13.85B
Revenue Rankings